Study supports glucocorticoid tapering in patients achieving disease control on tocilizumab

The results of a randomised controlled trial presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate high levels of treatment success in approximately two thirds of patients despite tapered glucocorticoid (GC) discontinuation, while a small loss of disease control was observed at the total study population level.

Top News

Ain't No God; don't even think about theism

UnFox News: not a propaganda arm of the Republican party